Description

Turinabolos 25 (Tbol) 100 tabs | Domestic-supply

Turinabol (4-Chlorodehydromethyltestosterone) – 25mg x 100 Tablets

Product Overview

Turinabol represents a unique oral anabolic steroid developed by Jenepharm in 1965, distinguished by its separation of anabolic and androgenic properties. This compound, chemically designated as 4-chlorodehydromethyltestosterone, combines structural elements of both methandrostanolone (Dianabol) and 4-chlorotestosterone to create a steroid with a favorable therapeutic profile.

Each tablet contains 25mg of pharmaceutical-grade Turinabol, with 100 tablets provided per unit. The compound features a 16-hour half-life, necessitating twice-daily administration for optimal blood level maintenance.

Key Characteristics

Anabolic-Androgenic Profile

Turinabol exhibits an anabolic to androgenic ratio that makes it suitable for both male and female athletes. The compound demonstrates an androgenic rating of 6, significantly lower than testosterone, while maintaining meaningful anabolic activity for lean tissue preservation and development.

Non-Aromatizing Properties

This steroid does not convert to estrogen through the aromatase enzyme, eliminating estrogen-related side effects including gynecomastia, water retention, and estrogen-induced hypertension. Users maintain a dry, vascular appearance throughout the administration period.

SHBG Modulation

Turinabol possesses a high binding affinity for sex hormone-binding globulin (SHBG), preferentially binding to this protein over other anabolic steroids. This mechanism may allow co-administered compounds to remain in a free, unbound state, potentially enhancing their anabolic activity.

Therapeutic Applications

Performance Enhancement

Turinabol provides gradual, quality lean muscle tissue accumulation without dramatic weight fluctuations. Users typically experience moderate strength increases and improved muscle density, making this compound suitable for:

• Cutting cycles requiring muscle preservation during caloric restriction

• Off-season periods focused on quality tissue accrual

• Athletic performance enhancement where mass gain is secondary to functional improvement

• Body recomposition protocols

Female Athlete Use

The low androgenic rating makes Turinabol a consideration for female competitors, particularly in figure, fitness, and bikini divisions. Dosing protocols for female athletes typically range from 5-15mg daily, with cycle duration carefully monitored to minimize virilization risk.

Dosage Guidelines

Male Athletes

• Standard therapeutic range: 40-60mg daily

• Administration: Divided into two equal doses every 8-12 hours

• Cycle length: Typically 6-8 weeks

Female Athletes

• Figure/Fitness/Bikini competitors: 5-15mg daily

• Bodybuilding competitors: Variable based on individual response and risk tolerance

• Administration: Single daily dose or divided equally

Administration Protocol

The 16-hour half-life supports twice-daily administration to maintain stable plasma concentrations. Tablets should be taken with meals to optimize absorption and gastrointestinal tolerance. Morning and evening dosing schedules provide consistent exposure throughout the 24-hour cycle.

Side Effect Profile

Hepatotoxicity

As a C17-alpha alkylated compound, Turinabol undergoes hepatic metabolism that may elevate liver enzyme levels. The compound demonstrates a relatively mild hepatotoxic profile compared to other oral agents, though regular monitoring is recommended during administration.

Cardiovascular Considerations

Turinabol can affect lipid profiles, typically reducing HDL cholesterol while increasing LDL cholesterol. The absence of estrogenic activity means this compound does not provide estrogenic cardioprotective effects, potentially increasing cardiovascular risk factors.

Androgenic Side Effects

The low androgenic rating minimizes traditional androgenic side effects including:

• Hair loss in genetically predisposed individuals

• Acne and seborrhea

• Prostate stimulation

• Aggression or mood changes

Virilization in Female Users

Female athletes should monitor for signs of virilization, including:

• Voice deepening

• Clitoral enlargement

• Hirsutism

• Menstrual irregularities

Storage and Handling

Store at room temperature, protected from light and moisture. Keep out of reach of children. Use within the manufacturer’s expiration date for optimal potency.

---

Top 10 Frequently Asked Questions

1. What is Turinabol’s detection time in drug testing?

Turinabol has a detection window of approximately 8-10 weeks following the last administration. Advanced testing methods can detect metabolites for extended periods, particularly with repeated or high-dose exposure.

2. Can Turinabol be used during a cutting cycle?

Yes, Turinabol is particularly effective during cutting cycles due to its non-aromatizing properties and ability to preserve lean muscle tissue during caloric deficit. The compound promotes a dry, hard appearance without water retention.

3. What is the recommended cycle duration for Turinabol?

Typical cycle duration ranges from 6-8 weeks for men and 4-6 weeks for women. Extended use beyond these periods may increase hepatotoxicity risk and testosterone suppression. Cycle length should be based on individual goals and response.

4. Is post-cycle therapy required after Turinabol use?

Yes, Turinabol suppresses endogenous testosterone production. A comprehensive post-cycle therapy protocol is recommended following any Turinabol cycle, utilizing compounds such as Clomid or Nolvadex to restore natural production.

5. Can Turinabol be stacked with other compounds?

Turinabol stacks effectively with various injectable steroids including testosterone, equipoise, and Deca-Durabolin. The SHBG-binding properties may enhance the effectiveness of stacked compounds with weaker binding affinity.

6. What are the signs of liver toxicity with Turinabol?

Signs may include elevated liver enzymes, jaundice, dark urine, fatigue, and abdominal pain. Regular liver function testing is recommended, and administration should be discontinued if marked elevations occur.

7. How does Turinabol compare to Dianabol?

Turinabol provides more gradual, quality gains with significantly fewer androgenic and estrogenic side effects compared to Dianabol. Weight gain is less dramatic but tissue quality is often superior.

8. Can female athletes safely use Turinabol?

Female athletes can use Turinabol at lower dosages (5-15mg daily) with minimal virilization risk. However, individual susceptibility varies, and close monitoring for androgenic side effects is essential.

9. What is the half-life of Turinabol?

Turinabol has a half-life of approximately 16 hours, supporting twice-daily dosing for consistent blood levels.

10. Does Turinabol cause hair loss?

Turinabol’s low androgenic rating significantly reduces the risk of hair loss compared to compounds with higher androgenic activity. However, individuals with genetic predisposition may still experience some degree of shedding.

---

Purchase Information

Secure your supply of pharmaceutical-grade Turinabol at our verified online pharmacy. We offer competitive pricing, discreet packaging, and guaranteed delivery.

[Call to Action: Visit https://anabolicsteroidsonline.shop/ to place your order and experience the proven benefits of Turinabol for your performance enhancement goals.]

Our product sourcing ensures pharmaceutical quality standards with third-party testing verification available upon request.

---

Important Medical Disclaimer

This product information is provided for educational purposes only. Anabolic steroids should only be used under qualified medical supervision. Unauthorized possession, distribution, or use may violate applicable laws in your jurisdiction. Consult with a healthcare provider before beginning any anabolic steroid protocol.

---

References and Reputable Sources

For additional information on anabolic steroid pharmacology and safety, please consult:

• National Institute on Drug Abuse (NIDA): https://www.drugabuse.gov/

• United States Anti-Doping Agency (USADA): https://www.usada.org/

• World Anti-Doping Agency (WADA): https://www.wada-ama.org/

• PubMed Central (PMC): https://www.ncbi.nlm.nih.gov/pmc/

• Endocrine Society: https://www.endocrine.org/

• Journal of Clinical Endocrinology and Metabolism: https://academic.oup.com/jcem

• National Institutes of Health (NIH): https://www.nih.gov/

• American College of Sports Medicine: https://www.acsm.org/

• International Olympic Committee (IOC) Medical: https://www.olympic.org/medical

• Mayo Clinic Sports Medicine: https://www.mayoclinic.org/medical-professionals/sports-